United States · FDA National Drug Code directory

Terbinafine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72162-2539_8fd1e92a-7e29-4ed1-8c8e-dcd201bd53e9
Product NDC
72162-2539
Form
TABLET
Composition / generic term
Terbinafine Hydrochloride
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20070702
Source listing expiry
20261231

Source-listed ingredients

  • TERBINAFINE HYDROCHLORIDE — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (72162-2539-1) · 72162-2539-1
  • 30 TABLET in 1 BOTTLE (72162-2539-3) · 72162-2539-3

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →